The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.
about
Interferon beta for secondary progressive multiple sclerosisCharacterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imagingImaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques.The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials.Imaging of multiple sclerosis: role in neurotherapeutics.Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.Magnetization transfer imaging in multiple sclerosis.MRI to monitor treatment efficacy in multiple sclerosis.Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.Progressive multiple sclerosis and gray matter pathology: an MRI perspective.Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.Magnetization transfer magnetic resonance imaging in the assessment of neurological diseases.Whole brain and localized magnetization transfer measurements are associated with cognitive impairment in patients infected with human immunodeficiency virus.Magnetization transfer MRI in multiple sclerosis.Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.Causes, effects and connectivity changes in MS-related cognitive decline.The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis
P2860
Q24203879-161ACF47-B9AA-463F-9672-E4A64E54F734Q24645501-ACFC31D7-06A6-4F52-9F58-2291406A5492Q30940046-7C057827-8DC7-489D-981C-E14DE30A2EAEQ30953733-909ED54C-5DA1-49C3-AE84-63F660C9E468Q30989935-7109504A-FC5A-4B2E-B9CE-528A1DC4970EQ31015218-E203E0C3-1A58-4766-83F6-9F775EA298AEQ31027961-EC1DBBEB-D411-484E-913A-C70B291DBC10Q31108872-3D577FAC-699B-4885-B796-6C887F6E2230Q31117157-66C29F7E-5128-4FC3-BFAD-38693A6CC386Q33381171-DBCCB226-6351-40C5-B258-1A7BF79353FEQ33852170-C62FE825-9A45-4806-A83A-F71B5A6583A5Q34014627-49FE74CD-6A19-4B9B-9CC8-B4A8C863844AQ34156824-426E72B1-1677-49CC-ADCB-440C309984DFQ35529707-44D795DF-E6C7-4ED9-AB3E-BEFD3DDC37F1Q35620086-388DCD2B-7E6A-40B7-B959-A2648F95A663Q35883422-853B17F1-2CAB-4E98-A864-F229EE4905E7Q36631814-60A6BB29-EA7C-4365-AD93-90A72E47A3D2Q36787481-1B207E4D-3CE8-49D8-BD30-CBC83987CDF1Q37142971-C00882D4-1A9D-48D4-814F-BD32B8CCB129Q40430109-3F691C8F-B550-4542-B232-05D699E32EF4Q47147953-0737A4CC-ABC3-4E16-A117-9F85BEA8422AQ48168382-2D7446E4-498D-4361-BA76-66B6E4603F82Q48340191-C671CE1D-C00F-401E-8300-D8A42D21B7C1Q48565199-DBE11FED-37BA-4D13-B3C7-39B76202E8A1Q48712550-30A31C08-13C5-4E89-94F6-7E910473A38CQ57911818-C105F35B-D550-4D25-A76C-EB24DB5CBBE9
P2860
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The effect of interferon beta- ...... I in secondary progressive MS.
@en
The effect of interferon beta- ...... I in secondary progressive MS.
@nl
type
label
The effect of interferon beta- ...... I in secondary progressive MS.
@en
The effect of interferon beta- ...... I in secondary progressive MS.
@nl
prefLabel
The effect of interferon beta- ...... I in secondary progressive MS.
@en
The effect of interferon beta- ...... I in secondary progressive MS.
@nl
P2093
P1433
P1476
The effect of interferon beta- ...... I in secondary progressive MS.
@en
P2093
A J Thompson
C Pozzilli
D H Miller
J H T M van Waesberghe
K Beckmann
P304
P356
10.1212/01.WNL.0000049929.27032.29
P407
P577
2003-03-01T00:00:00Z